BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 9951493)

  • 21. Tranexamic acid in the prevention of secondary haemorrhage after traumatic hyphaema.
    Uusitalo RJ; Saari MS; Aine E; Saari KM
    Acta Ophthalmol (Copenh); 1981 Aug; 59(4):539-45. PubMed ID: 7315210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid.
    Beiran I; Talmon T; Miller B
    Isr Med Assoc J; 2002 Nov; 4(11):1009-10. PubMed ID: 12489492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use.
    Phupong V; Sophonsritsuk A; Taneepanichskul S
    Contraception; 2006 Mar; 73(3):253-6. PubMed ID: 16472565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Traumatic eye hemorrhage (hyphema) treated with the antifibrinolytic preparation tranexamic acid].
    Bramsen T
    Ugeskr Laeger; 1977 Jun; 139(24):1422-4. PubMed ID: 878038
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is topical corticosteroid necessary in traumatic hyphema?
    Türkoğlu EB; Celik T; Celik E; Ozkan N; Bursalı O; Coşkun SB; Alagoz G
    J Fr Ophtalmol; 2014 Oct; 37(8):613-7. PubMed ID: 25199483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors related to the incidence of secondary haemorrhage in 462 patients with traumatic hyphema.
    Ng CS; Strong NP; Sparrow JM; Rosenthal AR
    Eye (Lond); 1992; 6 ( Pt 3)():308-12. PubMed ID: 1446767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of tranexamic acid mouthwash to prevent postoperative bleeding in oral surgery patients on oral anticoagulant medication.
    Gaspar R; Brenner B; Ardekian L; Peled M; Laufer D
    Quintessence Int; 1997 Jun; 28(6):375-9. PubMed ID: 9477900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
    Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Traumatic hyphema: clinical study of 149 cases.
    Yospaiboon Y; Sangveejit J; Suwanwatana C
    J Med Assoc Thai; 1989 Sep; 72(9):520-6. PubMed ID: 2809458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary hemorrhage in traumatic hyphema. Predictive factors for selective prophylaxis.
    Fong LP
    Ophthalmology; 1994 Sep; 101(9):1583-8. PubMed ID: 8090460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Traumatic hyphaema treated with the antifibrinolytic drug tranexamic acid.
    Bramsen T
    Acta Ophthalmol (Copenh); 1976 Apr; 54(2 p):250-6. PubMed ID: 946728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranexamic acid in patients with hemoptysis.
    Tscheikuna J; Chvaychoo B; Naruman C; Maranetra N
    J Med Assoc Thai; 2002 Apr; 85(4):399-404. PubMed ID: 12118485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of antifibrinolytica on traumatic hyphaema and corneal oedema.
    Bramsen T
    Acta Ophthalmol Suppl; 1980; (145):1-53. PubMed ID: 6257028
    [No Abstract]   [Full Text] [Related]  

  • 35. Meta-analysis of systemic anti-fibrinolytics in traumatic hyphaema.
    Aylward GW; Dunlop IS; Little BC
    Eye (Lond); 1994; 8 ( Pt 4)():440-2. PubMed ID: 7821469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical aminocaproic acid to prevent rebleeding in cases of traumatic hyphema.
    Karkhaneh R; Naeeni M; Chams H; Abdollahi M; Mansouri MR
    Eur J Ophthalmol; 2003; 13(1):57-61. PubMed ID: 12635675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
    Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
    J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminocaproic acid versus prednisone for the treatment of traumatic hyphema. A randomized clinical trial.
    Farber MD; Fiscella R; Goldberg MF
    Ophthalmology; 1991 Mar; 98(3):279-86. PubMed ID: 2023746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminocaproic acid decreases secondary hemorrhage after traumatic hyphema.
    McGetrick JJ; Jampol LM; Goldberg MF; Frenkel M; Fiscella RG
    Arch Ophthalmol; 1983 Jul; 101(7):1031-3. PubMed ID: 6870623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.